Use of PEG-asparaginase in newly diagnosed adults with standard-risk acute lymphoblastic leukemia compared with E. coli-asparaginase: a retrospective single-center study.
about
Efficacy and safety of native versus pegylated Escherichia coli asparaginase for treatment of adults with high-risk, Philadelphia chromosome-negative acute lymphoblastic leukemia.Asparagine synthetase expression is associated with the sensitivity to asparaginase in extranodal natural killer/T-cell lymphoma in vivo and in vitro
P2860
Use of PEG-asparaginase in newly diagnosed adults with standard-risk acute lymphoblastic leukemia compared with E. coli-asparaginase: a retrospective single-center study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Use of PEG-asparaginase in new ...... ospective single-center study.
@en
Use of PEG-asparaginase in new ...... ospective single-center study.
@nl
type
label
Use of PEG-asparaginase in new ...... ospective single-center study.
@en
Use of PEG-asparaginase in new ...... ospective single-center study.
@nl
prefLabel
Use of PEG-asparaginase in new ...... ospective single-center study.
@en
Use of PEG-asparaginase in new ...... ospective single-center study.
@nl
P2093
P2860
P356
P1433
P1476
Use of PEG-asparaginase in new ...... ospective single-center study.
@en
P2093
Cheng-Cheng Liu
Jing-Hua Wang
Meng-Yuan Zhu
Wei-da Wang
Wen-Jian Liu
P2860
P2888
P356
10.1038/SREP39463
P407
P577
2016-12-21T00:00:00Z
P6179
1051517661